Association of the British Pharmaceutical Industry
@abpi.bsky.social
Medicines and vaccines are transforming our lives like never before. We represent the companies that make them possible. 📨 [email protected]
Despite continued advances in cancer research, UK patients can access fewer cancer medicines through the NHS than patients in comparable European countries.
Find out more about improving access to cancer medicines:
www.abpi.org.uk/publications...
Find out more about improving access to cancer medicines:
www.abpi.org.uk/publications...
January 27, 2026 at 10:48 AM
Despite continued advances in cancer research, UK patients can access fewer cancer medicines through the NHS than patients in comparable European countries.
Find out more about improving access to cancer medicines:
www.abpi.org.uk/publications...
Find out more about improving access to cancer medicines:
www.abpi.org.uk/publications...
What drives company decisions on new medicine launches and UK investment?
The findings of ABPI's 2025 Medicines Impact and Investment Survey track how UK policy conditions influence companies' investment and prioritisation decisions for medicines launches.
www.abpi.org.uk/media/blogs/...
The findings of ABPI's 2025 Medicines Impact and Investment Survey track how UK policy conditions influence companies' investment and prioritisation decisions for medicines launches.
www.abpi.org.uk/media/blogs/...
What drives company decisions on new medicine launches and UK investment?
In this piece, David Watson, ABPI Executive Director of Patient Access, discusses the findings of ABPI's 2025 Medicines Impact and Investment Survey, which aims to understand how UK policy conditions ...
www.abpi.org.uk
January 26, 2026 at 10:13 AM
What drives company decisions on new medicine launches and UK investment?
The findings of ABPI's 2025 Medicines Impact and Investment Survey track how UK policy conditions influence companies' investment and prioritisation decisions for medicines launches.
www.abpi.org.uk/media/blogs/...
The findings of ABPI's 2025 Medicines Impact and Investment Survey track how UK policy conditions influence companies' investment and prioritisation decisions for medicines launches.
www.abpi.org.uk/media/blogs/...
At the moment, NHS patients with blood cancer can only access half of the approved medicines for their condition.
Reviewing how these medicines are valued is a first step to giving UK patients the treatments that could save or prolong their lives.
Learn more: www.ourcommongoal.org.uk/blood-cancer/
Reviewing how these medicines are valued is a first step to giving UK patients the treatments that could save or prolong their lives.
Learn more: www.ourcommongoal.org.uk/blood-cancer/
January 20, 2026 at 12:48 PM
At the moment, NHS patients with blood cancer can only access half of the approved medicines for their condition.
Reviewing how these medicines are valued is a first step to giving UK patients the treatments that could save or prolong their lives.
Learn more: www.ourcommongoal.org.uk/blood-cancer/
Reviewing how these medicines are valued is a first step to giving UK patients the treatments that could save or prolong their lives.
Learn more: www.ourcommongoal.org.uk/blood-cancer/
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK.
Rethinking the way such medicines are valued and approved is a crucial first step in increasing access to life-extending care for more UK patients.
Find out more: www.ourcommongoal.org.uk
Rethinking the way such medicines are valued and approved is a crucial first step in increasing access to life-extending care for more UK patients.
Find out more: www.ourcommongoal.org.uk
January 6, 2026 at 1:45 PM
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK.
Rethinking the way such medicines are valued and approved is a crucial first step in increasing access to life-extending care for more UK patients.
Find out more: www.ourcommongoal.org.uk
Rethinking the way such medicines are valued and approved is a crucial first step in increasing access to life-extending care for more UK patients.
Find out more: www.ourcommongoal.org.uk
It's time to emphasise the economics in health economics. Victoria Jordan discusses the health economics of the UK-US Economic Prosperity Deal and plans increase NICE's baseline threshold use, the first change since its introduction in the early 2000s. abpi.uksouth01.umbraco.io/media/blogs/...
Time to emphasise the economics in health economics
Victoria Jordan, ABPI Value and Access Policy Director, discusses the Health Economics of the UK-US Economic Prosperity Deal and the commitment to increase NICE's baseline threshold use, the first cha...
abpi.uksouth01.umbraco.io
January 5, 2026 at 9:58 AM
It's time to emphasise the economics in health economics. Victoria Jordan discusses the health economics of the UK-US Economic Prosperity Deal and plans increase NICE's baseline threshold use, the first change since its introduction in the early 2000s. abpi.uksouth01.umbraco.io/media/blogs/...
Alzheimer’s devastates the lives of patients and their families, costing billions in care.
New treatments that can slow the disease’s progression in its early stages have recently been licensed in the UK - yet NHS patients are still being denied access.
Find out more: www.ourcommongoal.org.uk
New treatments that can slow the disease’s progression in its early stages have recently been licensed in the UK - yet NHS patients are still being denied access.
Find out more: www.ourcommongoal.org.uk
December 16, 2025 at 10:18 AM
Alzheimer’s devastates the lives of patients and their families, costing billions in care.
New treatments that can slow the disease’s progression in its early stages have recently been licensed in the UK - yet NHS patients are still being denied access.
Find out more: www.ourcommongoal.org.uk
New treatments that can slow the disease’s progression in its early stages have recently been licensed in the UK - yet NHS patients are still being denied access.
Find out more: www.ourcommongoal.org.uk
Reposted by Association of the British Pharmaceutical Industry
#ABSWawards
As we prepare for the ABSW Awards 2026, we want to thank the partners whose continued support helps us celebrate excellence in science journalism...
@abpi.bsky.social
Dr Katharine Giles Fund
@royalsociety.org
AlphaGalileo
Want to be an ABSW Awards partner?
Find how👉 zurl.co/gPGgo
As we prepare for the ABSW Awards 2026, we want to thank the partners whose continued support helps us celebrate excellence in science journalism...
@abpi.bsky.social
Dr Katharine Giles Fund
@royalsociety.org
AlphaGalileo
Want to be an ABSW Awards partner?
Find how👉 zurl.co/gPGgo
December 15, 2025 at 1:00 PM
#ABSWawards
As we prepare for the ABSW Awards 2026, we want to thank the partners whose continued support helps us celebrate excellence in science journalism...
@abpi.bsky.social
Dr Katharine Giles Fund
@royalsociety.org
AlphaGalileo
Want to be an ABSW Awards partner?
Find how👉 zurl.co/gPGgo
As we prepare for the ABSW Awards 2026, we want to thank the partners whose continued support helps us celebrate excellence in science journalism...
@abpi.bsky.social
Dr Katharine Giles Fund
@royalsociety.org
AlphaGalileo
Want to be an ABSW Awards partner?
Find how👉 zurl.co/gPGgo
Publication of 'A Common Understanding 2025' marked an important milestone for collaborative working in Scotland earlier this year.
It shows how partnership across industry, academia & the NHS can improve patient care & drive innovation.
www.gov.scot/publications...
It shows how partnership across industry, academia & the NHS can improve patient care & drive innovation.
www.gov.scot/publications...
December 16, 2025 at 9:11 AM
Publication of 'A Common Understanding 2025' marked an important milestone for collaborative working in Scotland earlier this year.
It shows how partnership across industry, academia & the NHS can improve patient care & drive innovation.
www.gov.scot/publications...
It shows how partnership across industry, academia & the NHS can improve patient care & drive innovation.
www.gov.scot/publications...
We’re proud to share our guidance on creating successful NHS-industry partnerships in Northern Ireland’s health & social care system.
Developed with @niconfederation.bsky.social, it’s designed to accelerate innovation and improve patient outcomes. www.abpi.org.uk/publications...
Developed with @niconfederation.bsky.social, it’s designed to accelerate innovation and improve patient outcomes. www.abpi.org.uk/publications...
December 15, 2025 at 3:01 PM
We’re proud to share our guidance on creating successful NHS-industry partnerships in Northern Ireland’s health & social care system.
Developed with @niconfederation.bsky.social, it’s designed to accelerate innovation and improve patient outcomes. www.abpi.org.uk/publications...
Developed with @niconfederation.bsky.social, it’s designed to accelerate innovation and improve patient outcomes. www.abpi.org.uk/publications...
Earlier this year we launched joint guidance with @welshnhsconfed.bsky.social to help the NHS and industry work together more confidently, transparently & effectively.
📘 Download here to create successful partnerships for your organisation www.nhsconfed.org/publications...
#PartnershipWorking
📘 Download here to create successful partnerships for your organisation www.nhsconfed.org/publications...
#PartnershipWorking
December 12, 2025 at 1:54 PM
Earlier this year we launched joint guidance with @welshnhsconfed.bsky.social to help the NHS and industry work together more confidently, transparently & effectively.
📘 Download here to create successful partnerships for your organisation www.nhsconfed.org/publications...
#PartnershipWorking
📘 Download here to create successful partnerships for your organisation www.nhsconfed.org/publications...
#PartnershipWorking
NHS–industry partnership guidance is now in place across all 4 UK nations.
Developed with @nhsconfed.org, @welshnhsconfed.bsky.social, @niconfederation.bsky.social, and the Scottish Government, these frameworks support better outcomes for patients ⬇️
Find out more at www.abpi.org.uk/partnerships/
Developed with @nhsconfed.org, @welshnhsconfed.bsky.social, @niconfederation.bsky.social, and the Scottish Government, these frameworks support better outcomes for patients ⬇️
Find out more at www.abpi.org.uk/partnerships/
December 11, 2025 at 9:42 AM
NHS–industry partnership guidance is now in place across all 4 UK nations.
Developed with @nhsconfed.org, @welshnhsconfed.bsky.social, @niconfederation.bsky.social, and the Scottish Government, these frameworks support better outcomes for patients ⬇️
Find out more at www.abpi.org.uk/partnerships/
Developed with @nhsconfed.org, @welshnhsconfed.bsky.social, @niconfederation.bsky.social, and the Scottish Government, these frameworks support better outcomes for patients ⬇️
Find out more at www.abpi.org.uk/partnerships/
The VPAG payment rate for newer medicines will be 14.5% in 2026. With the addition of the 1% investment programme, the total rebate for newer medicines in 2026 will be 15.5% of revenues.
www.abpi.org.uk/media/news/2...
www.abpi.org.uk/media/news/2...
VPAG payment rate for newer medicines will be 14.5% in 2026
The government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5 per cent, down from a record 22.5 pe...
www.abpi.org.uk
December 10, 2025 at 9:39 AM
The VPAG payment rate for newer medicines will be 14.5% in 2026. With the addition of the 1% investment programme, the total rebate for newer medicines in 2026 will be 15.5% of revenues.
www.abpi.org.uk/media/news/2...
www.abpi.org.uk/media/news/2...
There’s been a drop in ppl participating in interventional industry clinical trials 📉
There are many potential reasons for this - lots of action underway to fix it 🔧
We're proposing further measures in our latest report.
abpi.org.uk/publications... @nihr.bsky.social
There are many potential reasons for this - lots of action underway to fix it 🔧
We're proposing further measures in our latest report.
abpi.org.uk/publications... @nihr.bsky.social
December 2, 2025 at 4:51 PM
There’s been a drop in ppl participating in interventional industry clinical trials 📉
There are many potential reasons for this - lots of action underway to fix it 🔧
We're proposing further measures in our latest report.
abpi.org.uk/publications... @nihr.bsky.social
There are many potential reasons for this - lots of action underway to fix it 🔧
We're proposing further measures in our latest report.
abpi.org.uk/publications... @nihr.bsky.social
Did you know the 150-day target for setting up industry clinical trials has 3 parts? ⏱️🧪
We’re on track with some — but others need work.
Read our latest report: www.abpi.org.uk/publications... @nihr.bsky.social
We’re on track with some — but others need work.
Read our latest report: www.abpi.org.uk/publications... @nihr.bsky.social
December 2, 2025 at 11:47 AM
Did you know the 150-day target for setting up industry clinical trials has 3 parts? ⏱️🧪
We’re on track with some — but others need work.
Read our latest report: www.abpi.org.uk/publications... @nihr.bsky.social
We’re on track with some — but others need work.
Read our latest report: www.abpi.org.uk/publications... @nihr.bsky.social
🚨 Today's US–UK trade agreement "...is an important step towards ensuring patients can access the innovative medicines needed to improve wider NHS health outcomes.”
Read the full response from our Chief Executive
@torbett.bsky.social
abpi.org.uk/media/news/2...
Read the full response from our Chief Executive
@torbett.bsky.social
abpi.org.uk/media/news/2...
UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI
Industry hopes the new trade agreement will allow more innovative medicines to reach a greater number of NHS patients and will be a positive step in supporting the UK life sciences industry.
abpi.org.uk
December 1, 2025 at 3:32 PM
🚨 Today's US–UK trade agreement "...is an important step towards ensuring patients can access the innovative medicines needed to improve wider NHS health outcomes.”
Read the full response from our Chief Executive
@torbett.bsky.social
abpi.org.uk/media/news/2...
Read the full response from our Chief Executive
@torbett.bsky.social
abpi.org.uk/media/news/2...
Acid Sphingomyelinase Deficiency (ASMD) is a rare disease that shortens the lives of children & adults.
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
November 26, 2025 at 10:52 AM
Acid Sphingomyelinase Deficiency (ASMD) is a rare disease that shortens the lives of children & adults.
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
Sepsis is the body's reaction to a serious infection and is responsible thousands of deaths a year.
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
November 24, 2025 at 11:55 AM
Sepsis is the body's reaction to a serious infection and is responsible thousands of deaths a year.
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
Treating pneumonia without antibiotics is like a hot-air balloon without gas.
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
November 21, 2025 at 12:41 PM
Treating pneumonia without antibiotics is like a hot-air balloon without gas.
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
NHS patients with blood cancer can only access half the approved medicines for their condition despite many of these treatments being available in other countries
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
November 21, 2025 at 11:23 AM
NHS patients with blood cancer can only access half the approved medicines for their condition despite many of these treatments being available in other countries
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
Scotland's Life Sciences Strategy is out today, setting out a vision of how to boost the sector to benefit Scottish patients and the economy. @scottishgovernment.bsky.social
Read our response: www.abpi.org.uk/media/news/2...
Read our response: www.abpi.org.uk/media/news/2...
Scotland's life sciences strategy is a welcome vision that must be matched with delivery, says ABPI
The Strategy aims to create the most effective environment for developing, testing, manufacturing and commercialising life sciences innovation.
www.abpi.org.uk
November 20, 2025 at 1:15 PM
Scotland's Life Sciences Strategy is out today, setting out a vision of how to boost the sector to benefit Scottish patients and the economy. @scottishgovernment.bsky.social
Read our response: www.abpi.org.uk/media/news/2...
Read our response: www.abpi.org.uk/media/news/2...
Treatments for kidney disease are under threat from antibiotic resistance.
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
November 19, 2025 at 11:47 AM
Treatments for kidney disease are under threat from antibiotic resistance.
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
ABPI Wales Head of External Affairs Joe Castle was joined by the Welsh First Minister @ the Senedd to discuss joint @welshnhsconfed.bsky.social guidance covering how industry & the NHS can work together to improve patient outcomes & support innovation across Wales.
www.nhsconfed.org/publications...
www.nhsconfed.org/publications...
November 18, 2025 at 4:15 PM
ABPI Wales Head of External Affairs Joe Castle was joined by the Welsh First Minister @ the Senedd to discuss joint @welshnhsconfed.bsky.social guidance covering how industry & the NHS can work together to improve patient outcomes & support innovation across Wales.
www.nhsconfed.org/publications...
www.nhsconfed.org/publications...
What if our treatments no longer worked?
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
November 18, 2025 at 11:19 AM
What if our treatments no longer worked?
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK, even though people in the US and many European countries can access them.
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
November 11, 2025 at 10:45 AM
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK, even though people in the US and many European countries can access them.
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
Reposted by Association of the British Pharmaceutical Industry
